Inbiogen Co. Ltd. (101140) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inbiogen Co. Ltd. (101140:KRX), powered by AI.

Current Price
₩7,100
P/E Ratio
-50.3
Market Cap
71.3B
Sector
Consumer Cyclical
What is the Inbiogen Co. Ltd. stock price forecast?

Inbiogen Co. Ltd. is currently trading at ₩7,100. View real-time AI analysis on Alpha Lenz.

What is Inbiogen Co. Ltd. insider trading activity?

View the latest insider trading data for Inbiogen Co. Ltd. on Alpha Lenz.

What is Inbiogen Co. Ltd.'s P/E ratio?

Inbiogen Co. Ltd.'s P/E ratio is -50.3.

Inbiogen Co. Ltd.

KRX · 101140
₩7,100+140(+2.01%)Market closedKRX regular session 09:00–15:30 KST
Ask about Inbiogen Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Inbiogen Co. Ltd. trades at a P/E of -50.3 (undervalued) with modest ROE of -0.9%.

Ask for details

Company Overview

Inbiogen Co. Ltd. is a biotechnology company engaged in the development and manufacturing of biopharmaceutical products. The primary function of Inbiogen is to innovate and provide therapeutic solutions that address unmet medical needs, with an emphasis on the research and commercialization of novel drugs. Inbiogen plays a significant role in the healthcare sector, contributing to advancements in medical treatments and therapies that cater to a wide range of health conditions. Its focus encompasses areas such as oncology, infectious diseases, and metabolic disorders among others, highlighting its commitment to improving patient outcomes and quality of life. As a participant in the biopharmaceutical industry, Inbiogen's research initiatives and product pipelines are crucial to the sector's growth and competitiveness. With its research and development facilities, the company is at the forefront of pioneering medical breakthroughs and advancing biotechnology innovations on a global scale.

CEO강지연
SectorConsumer Cyclical
IndustryFootwear & Accessories
0

Company Statistics

FY 2025

Profile

₩71,313,933,600Market Cap
₩6,296,747,700Revenue
10.04MShares Out
0Employees

Margins

-5.52%Gross
-0.26%EBITDA
-68.81%Operating
-22.53%Pre-Tax
-22.53%Net

Valuation

-50.27P/E
0.45P/B
11.33EV/Sales
-4395.75EV/EBITDA
-12.74P/FCF

Growth (CAGR)

-15.45%Rev 3Yr
-9.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.88%ROA
-0.89%ROE
-0.83%ROIC

Financial Health

₩901,695,840Cash & Cash Equivalents
₩1,448,182,340Net Debt
1.49%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Inbiogen Co. Ltd. (ticker: 101140) is a company listed on KRX in the Consumer Cyclical sector (Footwear & Accessories). Market cap is $71.3B.

The current price is ₩7,100 with a P/E ratio of -50.27x and P/B of 0.45x.

ROE is -0.89% and operating margin is -68.81%. Annual revenue is $6.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Inbiogen Co. Ltd. (101140) Stock Forecast 2026 ₩7,100 — Price, Financials & Analyst Targets | Alpha Lenz